|
|
|
|
|||||
|
|
|
CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.
A live webcast of the conference call will be available in the Events & Presentations section of the company’s investor website at investors.carlsmed.com. Participants may also join via telephone by registering here. A replay will be archived on the company’s website following completion of the call.
About Carlsmed
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
IR@Carlsmed.com
Media
Marketing@carlsmed.com
| Jul-22 | |
| May-05 | |
| Apr-28 | |
| Apr-14 | |
| Apr-01 | |
| Mar-07 | |
| Feb-26 | |
| Feb-26 | |
| Feb-25 | |
| Feb-23 | |
| Feb-19 | |
| Feb-18 | |
| Feb-11 | |
| Feb-10 | |
| Jan-12 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite